Business Standard

Sunday, December 22, 2024 | 09:43 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Haryana stops production at plant making cough syrups flagged by WHO

12 violations found at Maiden Pharmaceuticals' Sonipat facility, says state health minister

cough syrup, medicine, cold
Premium

File photo of cough syrup. Photo: Shutterstock

Sohini Das Mumbai
Haryana has halted production at Maiden Pharmaceuticals' Sonipat plant after the World Health Organization (WHO) last week said cough syrups produced made by the company could be linked to the deaths of 66 children in Gambia.

News agency ANI quoted health minister Anil Vij as saying that while laboratory reports of the samples collected from the company are awaited, the state had decided to halt total production at the plant. A joint inspection by the state Food and Drugs Administration and Central Drugs Standard Control Organisation (CDSCO) found 12 violations of good manufacturing practices in the Sonipat facility, he said.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in